Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 2.960
-0.005 (-0.17%)
Nov 10, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 5.34 billion as of November 9, 2026. It is the 12,328th most valuable company in the world and the 585th biggest in Hong Kong. Its market cap has decreased by 49.14% in one year.
Market Cap
5.34B
Enterprise Value
5.76B
Revenue
1.14B
Global Rank
Country Rank
#585 Hong Kong
PE Ratio
18.70
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 5.34B, a decrease of -54.90%. That is a compound annual growth rate of -15.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 5.34B | -40.44% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 7.33B |
| Shanghai Haohai Biological Technology | 7.26B |
| Nanjing Leads Biolabs | 7.13B |
| Shaanxi Micot Pharmaceutical Technology | 6.24B |
| CARsgen Therapeutics Holdings | 6.12B |
| Alphamab Oncology | 6.06B |
| CK Life Sciences Int'l., (Holdings) | 5.05B |
| Ascletis Pharma | 4.81B |